HealthDay on MSN19m
Obinutuzumab Efficacious for Renal Response in Lupus NephritisFor patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback